Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells

Cancer Letters

Volumn 148, Issue 1, 2000, Pages 65-71

  Kuwahara, Daisuke ^a,b   Tsutsumi, Kouichiro ^a   Kobayashi, Tetsuya ^c   Hasunuma, Tomoko ^b   Nishioka, Kusuki ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Rheumatology   (Japan)

^c Rheumatology Genetic Res Found S   (Japan)

Author keywords

Apoptosis; Caspase 9; Cisplatin; Head and neck squamous cell carcinoma cells

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CISPLATIN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD95; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033987113     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00315-8     Document Type: Article

References (28)

1. Gebbia V., Mantovani G., Farris A., Agostara B., Desogus A., Curreli L., Moschella F., DiGregorio C., Bajetta E., Gebbia N. Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study. Cancer. 79:1997;1394-1400.
2. Kojima H., Endo K., Moriyama H., Tanaka Y., Alnemri E.S., Slapak C.A., Teicher B., Kufe D., Datta R. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J. Biol. Chem. 273:1998;16647-16650.
3. Fulda S., Los M., Friesen C., Debatin K.M. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Int. J. Cancer. 76:1998;105-114.
4. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell. 91:1997;443-446.
5. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
6. Hofmann K., Bucher P., Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 22:1997;155-156.
7. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas- mediated apoptosis. Nature. 380:1996;723-726.
8. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:1998;2926-2930.
9. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
10. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
11. Mizutani Y., Yoshida O., Bonavida B. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). J. Urol. 160:1998;561-570.
12. Uslu R., Jewett A., Bonavida B. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis. Gynecol. Oncol. 62:1996;282-291.
13. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
14. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:1998;949-957.
15. Muller M., Strand S., Hug H., Heinemann E.M., Walczak H., Hofmann W.J., Stremmel W., Krammer P.H., Galle P.R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO- 1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99:1997;403-413.
16. Ferrari D., Stepczynska A., Los M., Wesselborg S., Schulze-Osthoff K. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J. Exp. Med. 188:1998;979-984.
17. Reed J.C. Cytochrome c: can't live with it - can't live without it [comment]. Cell. 91:1997;559-562.
18. Kim C.N., Wang X., Huang Y., Ibrado A.M., Liu L., Fang G., Bhalla K. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:1997;3115-3120.
19. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked [see comments]. Science. 275:1997;1129-1132.
20. Kuida K., Haydar T.F., Kuan C.Y., Taya C., Karasuyama H., Su M.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
21. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufuman S.A., Lowe S.W., Penninger J.M., Mak T.W.M. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
22. Adachi S., Cross A.R., Babior B.M., Gottlieb R.A. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J. Biol. Chem. 272:1997;21878-21882.
23. Friesen C., Herr I., Krammer P.H., Debatin K.M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2:1996;574-577.
24. Eischen C.M., Kottke T.J., Martins L.M., Basi G.S., Tung J.S., Earnshaw W.C., Leibson P.J., Kaufmann S.H. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 90:1997;935-943.
25. Moers C., Warskulat U., Muschen M., Even J., Niederacher D., Josien R., Koldovsky U., Beckmann M.W., Haussinger D. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin. Int. J. Cancer. 80:1999;564-572.
26. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis [see comments]. Science. 275:1997;1132-1136.
27. Hu Y., Benedict M.A., Wu D., Inohara N., Nunez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA. 95:1998;4386-4391.
28. Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S., Yoshino K., Okumura K., Yagita H. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1995;1777-1783.